The diagnosis and treatment of tardive disorders

William T. Dauer Md, Stanley Fahn Md, Robert E. Burke Md

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Drugs that block dopamine receptors (dopamine receptor blocking agents; DRBA) may cause a variety of movement disorder syndromes. Among these syndromes are the tardive disorders, which are characterized by an onset weeks to years after the start of DRBA therapy and persist or even worsen after DRBA discontinuation. The tardive disorders may sometimes be permanent. The most common tardive disorders are oral-buccal-lingual dyskinesia, tardive dystonia, and tardive akathisia. The clinical characteristics and treatment of these syndromes are reviewed. Initial evaluation of a patient with a tardive disorder should focus on whether the offending DRBA may be discontinued, and whether the symptoms are severe enough to warrant symptomatic therapy. If it is necessary to continue antipsychotic therapy, consideration should be given to the novel antipsychotic clozapine, which does not cause tardive syndromes and may even ameliorate them. In general, the dopamine depletors reserpine and tetrabenazine are the most effective agents in the symptomatic treatment of the tardive syndromes. Other medications used in the treatment of the tardive syndromes are also reviewed.

Original languageEnglish (US)
Pages (from-to)119-125
Number of pages7
JournalMedical Update for Psychiatrists
Volume3
Issue number4
DOIs
StatePublished - Jul 1 1998
Externally publishedYes

Fingerprint

Dopamine Receptors
Antipsychotic Agents
Drug-Induced Akathisia
Therapeutics
Tetrabenazine
Cheek
Clozapine
Reserpine
Dyskinesias
Movement Disorders
Tongue
Dopamine
Pharmaceutical Preparations
Tardive Dyskinesia

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

The diagnosis and treatment of tardive disorders. / Dauer Md, William T.; Fahn Md, Stanley; Burke Md, Robert E.

In: Medical Update for Psychiatrists, Vol. 3, No. 4, 01.07.1998, p. 119-125.

Research output: Contribution to journalArticle

Dauer Md, William T. ; Fahn Md, Stanley ; Burke Md, Robert E. / The diagnosis and treatment of tardive disorders. In: Medical Update for Psychiatrists. 1998 ; Vol. 3, No. 4. pp. 119-125.
@article{2d4fb044f7e54c6cb60ddb02844e9f40,
title = "The diagnosis and treatment of tardive disorders",
abstract = "Drugs that block dopamine receptors (dopamine receptor blocking agents; DRBA) may cause a variety of movement disorder syndromes. Among these syndromes are the tardive disorders, which are characterized by an onset weeks to years after the start of DRBA therapy and persist or even worsen after DRBA discontinuation. The tardive disorders may sometimes be permanent. The most common tardive disorders are oral-buccal-lingual dyskinesia, tardive dystonia, and tardive akathisia. The clinical characteristics and treatment of these syndromes are reviewed. Initial evaluation of a patient with a tardive disorder should focus on whether the offending DRBA may be discontinued, and whether the symptoms are severe enough to warrant symptomatic therapy. If it is necessary to continue antipsychotic therapy, consideration should be given to the novel antipsychotic clozapine, which does not cause tardive syndromes and may even ameliorate them. In general, the dopamine depletors reserpine and tetrabenazine are the most effective agents in the symptomatic treatment of the tardive syndromes. Other medications used in the treatment of the tardive syndromes are also reviewed.",
author = "{Dauer Md}, {William T.} and {Fahn Md}, Stanley and {Burke Md}, {Robert E.}",
year = "1998",
month = "7",
day = "1",
doi = "10.1016/S1082-7579(98)00016-8",
language = "English (US)",
volume = "3",
pages = "119--125",
journal = "Medical Update for Psychiatrists",
issn = "1082-7579",
number = "4",

}

TY - JOUR

T1 - The diagnosis and treatment of tardive disorders

AU - Dauer Md, William T.

AU - Fahn Md, Stanley

AU - Burke Md, Robert E.

PY - 1998/7/1

Y1 - 1998/7/1

N2 - Drugs that block dopamine receptors (dopamine receptor blocking agents; DRBA) may cause a variety of movement disorder syndromes. Among these syndromes are the tardive disorders, which are characterized by an onset weeks to years after the start of DRBA therapy and persist or even worsen after DRBA discontinuation. The tardive disorders may sometimes be permanent. The most common tardive disorders are oral-buccal-lingual dyskinesia, tardive dystonia, and tardive akathisia. The clinical characteristics and treatment of these syndromes are reviewed. Initial evaluation of a patient with a tardive disorder should focus on whether the offending DRBA may be discontinued, and whether the symptoms are severe enough to warrant symptomatic therapy. If it is necessary to continue antipsychotic therapy, consideration should be given to the novel antipsychotic clozapine, which does not cause tardive syndromes and may even ameliorate them. In general, the dopamine depletors reserpine and tetrabenazine are the most effective agents in the symptomatic treatment of the tardive syndromes. Other medications used in the treatment of the tardive syndromes are also reviewed.

AB - Drugs that block dopamine receptors (dopamine receptor blocking agents; DRBA) may cause a variety of movement disorder syndromes. Among these syndromes are the tardive disorders, which are characterized by an onset weeks to years after the start of DRBA therapy and persist or even worsen after DRBA discontinuation. The tardive disorders may sometimes be permanent. The most common tardive disorders are oral-buccal-lingual dyskinesia, tardive dystonia, and tardive akathisia. The clinical characteristics and treatment of these syndromes are reviewed. Initial evaluation of a patient with a tardive disorder should focus on whether the offending DRBA may be discontinued, and whether the symptoms are severe enough to warrant symptomatic therapy. If it is necessary to continue antipsychotic therapy, consideration should be given to the novel antipsychotic clozapine, which does not cause tardive syndromes and may even ameliorate them. In general, the dopamine depletors reserpine and tetrabenazine are the most effective agents in the symptomatic treatment of the tardive syndromes. Other medications used in the treatment of the tardive syndromes are also reviewed.

UR - http://www.scopus.com/inward/record.url?scp=0031721757&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031721757&partnerID=8YFLogxK

U2 - 10.1016/S1082-7579(98)00016-8

DO - 10.1016/S1082-7579(98)00016-8

M3 - Article

AN - SCOPUS:0031721757

VL - 3

SP - 119

EP - 125

JO - Medical Update for Psychiatrists

JF - Medical Update for Psychiatrists

SN - 1082-7579

IS - 4

ER -